Abbott will announce its financial results for the third quarter of 2026 on October 21 before the market opens. The company will host a live webcast of the earnings conference call at 8 a.m. Central time, accessible via Abbott's Investor Relations website. Abbott is a global healthcare leader with a broad portfolio including diagnostics, medical devices, nutritionals, and branded generic medicines, serving over 160 countries. Investors can expect detailed insights into Abbott's performance and outlook during the call.
Ahead of Abbott's third-quarter earnings call scheduled for October 21, the company's stock is trading steadily on Pluang. As of September 30, 2026, at 20:13 WIB, ABT shares are priced at USD 101.06, showing a slight 0.12% increase for the day. The stock holds a market capitalization of $174.68 billion and offers a dividend yield of 2.5%, with typical investors holding for about 96 days. Order activity on Pluang leans heavily toward selling, with 79% of orders being sell orders.
Abbott has launched SimpleScreen CRC, an FDA-approved blood test for colorectal cancer screening in adults aged 45 and older at average risk. This test offers a convenient alternative for those who decline or do not complete stool-based or visual scr...
Abbott Laboratories, Medtronic, and Becton Dickinson, three leading medical device companies, have each increased their dividends recently, continuing long streaks of annual raises—54 years for Abbott, 49 for Medtronic, and consistent growth for Bect...
